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CHAPTER 1 
Introduction 
Deoxyribonucleic Acid Structure and Damage 
Deoxyribonucleic acid (DNA) is an exceedingly important biomacromolecule responsible 
for storing the genetic information of cells.1 DNA has a distinct structure that allows it to be 
recognized by proteins such as the transcription machinery.2 Whenever the structure of DNA is 
perturbed via carcinogens or modifications, mutations can arise which have the potential to be 
detrimental to the cell. An example is UV-induced thymine dimers which have the ability to 
inhibit DNA synthesis.3 The mutagenic profiles of damaged DNA vary with the type of damage 
or lesions involved.  
 
 
  
Figure 1. General Structure of DNA4: 
A picture illustrating the DNA double helix as well as the base pairs. 
(A) Adenine, (B) Thymine, (C) Guanine, (D) Cytosine, (1) Phosphate backbone, (2) Base pairs, 
(3) Nitrogenous base 
	 2 
The most common structure of DNA is B-type double helix. While other structural forms 
of DNA exist, such as A-DNA and Z-DNA, B-DNA is the predominant form within the 
biological context.5 The DNA macromolecule has three main components: the phosphate 
backbone, the deoxyribose sugar moiety, and the nucleobase. The phosphate backbone orients 
the nucleosides correctly, and it is responsible for the net negative charge that DNA is known to 
have. The sugar moiety is one of the structural differences between DNA and RNA. In DNA, the 
sugar moiety is a deoxyribose sugar unit indicating that it does not have a hydroxyl group at the 
2’ position. Finally, connected to the deoxyribose sugar is the nucleobase responsible for the 
genetic information. There are four nucleobases in DNA: adenine (A), thymine (T), guanine (G), 
and cytosine (C) (Figure 2). 
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Figure 2. The four nitrogeneous bases connected to the deoxyribose sugar moiety which 
is connected to the phosphate backbone. 
	 3 
Adenine and guanine are the purines of the nucleobases while thymine and cytosine are 
the pyrimidines. These structures are highly important because they ultimately dictate how the 
double helix will form. Since the two strands of DNA are required to form the double helix, the 
nucleobases must form base pairs to each other on the opposite strands. Adenine and thymine 
form a Watson-Crick base pair with two hydrogen bonds, while guanine and cytosine form a 
similar base pair with three hydrogen bonds. Therefore, guanine and cytosine base pairs are more 
stable. The bonding network in DNA does provide stability to the overall macromolecule. 
However, substantial stability is achieved by the π-stacking (base-stacking) interactions between 
neighboring bases in the strands. Since the bases are aromatic, their π-electrons can conjugate 
and stabilize the DNA duplex structure. 
DNA damage has been a significant area of research. Genetic approaches to parse disease 
characteristics often revealed mutations in the DNA that caused downstream effects. Various 
types of mutations have been characterized; however, the shear complexity of the human genome 
has proven difficult to detail all of the mutations for every protein. As research has shifted to a 
proteomic perspective, research has demonstrated that the structures of interacting components in 
a biological system is significant for maintaining the function of those components. Therefore, 
by studying the structural perturbations that suspected carcinogens cause the global DNA 
structure, insight can be generated about how proteins will interact with these damaged 
oligonucleotides. By understanding the biological processing behind some of these lesions, there 
is the potential for more research to lead to better drugs or treatments for certain disorders. 
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Methyl Formamidopyrimidine 
Methylation of deoxyribonucleic acid (DNA) has been a growing area of interest in 
genomic studies, particularly with cytosine and guanine.6,9 With its relevance to epigenetic 
regulation and varying levels of damage it causes to DNA, more focus is being placed on 
understanding the mechanisms involved with methylation and the biological processing of its 
products. Methylation of DNA can be induced from various endogeneous, exogeneous, and 
occupational sources.7 Furthermore, a few chemotherapeutic agents are known methylating 
agents.8 Methyl-formamidopyrimidine (MeFapy; Figure 3) is a product of methylation that 
occurs in DNA.18 While it is hypothesized that tobacco carcinogens and food-associated 
nitrosamines can ultimately induce MeFapy-dG formation, chemotherapy drugs like 
temazolamide have been suggested to form MeFapy-dG lesions during methylation events.9 
 
 
 
 
MeFapy occurs in the context of guanine residues (dG) due to the nucleophilic nature of 
guanine’s N7 site.10 While Fapy-dG remains the simplest Fapy system to study, MeFapy-dG is 
an important step toward studying more complex alkylated Fapy species which is the 
fundamental significance of this work. As mentioned previously, it has been hypothesized that 
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Figure 3. Structure of MeFapy-dG. 
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MeFapy-dG is generated during the use of chemotherapy that uses methylating agents.11 The 
formation of MeFapy-dG differs from the generation of Fapy-dG lesions. Formation of MeFapy 
begins with methylation of guanine at the N7 position. This position has been classified as the 
most nucleophilic site in DNA which is crucial in the formation of MeFapy-dG.12 Once the 
guanine residue has been methylated to form 7-methylguanine (7-meG), the next step involves 
the addition of hydroxide to C8 follow by breaking the C8-N9 bond of the imidazole ring. 
Opening of the imidazole ring is slow at neutral pH, therefore depurination is favored at this pH 
range.13 However, under alkaline conditions, the ring opening reaction proceeds readily (Figure 
4). 
 
 
 
 
The precursor species to MeFapy-dG, 7-meG, has generally been assumed to be harmless 
and observed to occur often in DNA,17 yet evidence suggests that MeFapy-dG can be more 
detrimental to the cell in terms of cytoxicity. Work on MeFapy-dG and its interaction with 
various polymerases and enzymes is ongoing; however, previous work has detailed that MeFapy-
dG is a substrate for the human 8-oxo-G glycosylase enzyme (hOGG1) and the bacterial Fapy 
glycosylase enzyme (Fpg).14 When the lesion is present in a duplex, it becomes a very persistent 
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Figure 4. Proposed formation of MeFapy-dG. The N7 atom becomes methylated which leads to N7 
being positively charged. Under alkaline conditions, this positive charge is readily neutralized by a 
hydroxyl group. Then the imidazole ring ruptures to form MeFapy-dG. 
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lesion unlike its precursor 7-meG which was effectively repaired over time.15 The mutagenicity 
of MeFapy-dG is still being parsed; however, one of the more dominant mutations observed was 
the GàT transversion. Furthermore, the cytotoxic activity of MeFapy-dG has been shown 
multiple times in vitro.11 Interestingly, the mutagenicity of the lesion seems to be highly 
sequence dependent with differing mutagenic profiles based on the neighboring bases around the 
lesion.16 In the work by Christov et al. it was shown that MeFapy-dG was a strong block to 
replication in vitro.18 It was further hypothesized that the various anomers associated with 
MeFapy-dG were significantly related to its cytotoxic activity. The MeFapy-dG:C pair caused a 
strong thermodynamic destabilization of a DNA duplex by lowering the melting temperature 
relative to a normal G:C base pair. When examined in a polymerase bypass assay, MeFapy-dG 
was shown to be bypassed less efficiently than 8-oxoG by E. coli DNA polymerase I.19 As 
mentioned, MeFapy-dG can adopt various anomers (Figure 5) and rotamers (Figure 6) due to 
the increased degrees of conformational freedom permitted by the ruptured imidazole ring. The 
two anomers, β- and α- have interesting biological activities as the α-anomer was hypothesized 
to be the anomer responsible for blocking replication.20,21 
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Rotamers exist around the formyl group as well as various rotamers involving rotations 
of the N5 (previous N7 in dG) bond in MeFapy-dG.22 
 
 
 
 
Therefore, the work presented here sought to parse those structural characteristics of the 
MeFapy-dG lesion via NMR spectroscopy. 
Aminopyrene Introduction 
The polyaromatic hydrocarbon (PAH) 1-nitropyrene (1-NP) is an abundant chemical pollutant 
found in urban air particulates and diesel exhaust.23 Upon inhalation of 1-NP, it is metabolized 
via the nitroreduction pathway which leads to the formation of aminpyrene (Figure 7).24 
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The adduction sites of 1-NP has been characterized at the C8 and N2 positions on guanine 
residues. Most of the previous work on 1-NP and its metabolized product, aminopyrene (AP) has 
been at the C8 attachment point. 1-NP is reduced to N-hydroxy-1-aminopyrene which is 
responsible for adduction to DNA.25 Structural studies done on C8-AP-dG have found that the 
global B-DNA conformation is sustained and bypass of the lesion in the M13mp2 bacteriophage 
was efficient and almost error-free.26 However, the C8-AP-dG adduct ultimately displaced the 
guanine it was attached to into the major groove with the adduct intercalating into the duplex. 
Interestingly enough, due to the strength of the base stacking interactions induced by the AP 
adduct, the intercalation of the adduct actually stabilized the duplex.27 
The cellular mutagenicity of the adduct suggested that the mutations spectrum was 
organism-sequence dependent with frameshifts dominating in bacteria and GàT transversions in 
mammals.28,29 While bypass was efficient by low-fidelity polymerases, it was suggested that the 
adduct completely stalled high-fidelity replicative polymerases.30 
Little work has been done on N2-AP-dG; however, other adducts at the N2 position have 
been analyzed to use as a comparison. The structural analysis of N2-benzo[a]pyrene diol epoxide 
O2N ON HO2N H2N
Figure 7. The proposed path of formation for aminopyrene from 1-nitropyrene. 
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(Figure 6) in an 11-mer duplex was shown to be positioned in the minor groove, pointing in the 
5’ direction of the primary strand.31 Furthermore, the N2-B[a]P was shown to minimally perturb 
the B-DNA helix.32 While the the B[a]P structure is not immediately similar to AP, it does 
provide some insight into the context of bulky N2 adducts. 
Other bulky N2 adducts, such as N2-acetylaminofluorine (N2-AAF and N2-benzo[a]pyrene 
diol expoxide; Figure 8), had similar degrees of perturbation and were suggested to be repaired 
by nucleotide excision repair (NER) like other bulky adducts.33 
  
 
 
Likewise, N2-IQ-dG (Figure 9) was studied structurally, and it was found to displace the 
complementary base into the major groove. Ultimately, this allowed the IQ adduct to intercalate 
into the duplex with the modified base remaining in the anti configuration.34 
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Figure 8. N2-AAF (left) and N2-benzo[a]pyrene diol epoxide (right). 
	 10 
 
 
As previously mentioned with the adduct, large bulky adducts often require the TLS 
polymerases (often in the Y-family) to bypass them in the DNA. Polymerase bypass studies 
found that hPolκ was the most efficient enzyme at bypassing various bulky N2 adducts with 
hPolη showing signs of stalling and misincorporation.35 The work here seeks to explain the 
structural characteristics of the N2-AP-dG adduct (Figure 10). Since the adduct is attached near 
the hydrogen-bonding interface, it is hypothesized there will be some perturbance of the DNA 
structure. 
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Figure 10. N2-Aminopyrene-dG. 
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Structural Information by Nuclear Resonance Spectroscopy 
Structural biology and biophysical chemistry have developed powerful tools and methods 
to parse the structural characteristics of nucleic acids, proteins, and biological processes. There 
are various modalities used such as nuclear magnetic resonance spectroscopy (NMR), X-ray 
crystallography, computational methods, cryo electron microscopy (cryo-EM), small angle X-ray 
scattering (SAXS), and others. While all of these approaches are powerful, they are also limited 
in different ways. Therefore, it is common to use multiple modalities to complement one another. 
NMR has proven to be useful because it is able to generate solution structures of nucleic acid and 
proteins. This is a significant advantage because it is more closely related to biological 
conditions, unlike X-ray crystallography which can only generate static structures with no 
conclusive insight into dynamics. Multiple NMR experiments and pulse sequences can be used 
to generate structural information for nucleic acids. 
Correlation Spectroscopy (COSY): The COSY experiment is a 2D homonuclear experiment that 
measures through-bond interactions.36 Protons that are within three bonds of each other will be 
observable through the transfer of magnetization that occurs. Unlike TOCSY which can observe 
long distance through-bond interactions in a spin system, COSY is a short distance through-bond 
approach.37 For this project, the primary purpose of the COSY was to observe the H5-H6 scalar 
couplings of cytosines in the duplex. Ultimately, the information in COSY ensures that the 
correct number of cytosine cross-peaks are present, and it helps to simplify NOESY spectrum 
assignment since the chemical shifts of the cytosine cross-peaks will be the same in both 
experiments. 
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Nuclear Overhauser Effect Spectroscopy (NOESY): The NOESY pulse sequence revolves 
around the NOE (nuclear Overhauser effect) which is a transfer of magnetization through-
space.38,40 It is a 2D homonuclear approach like the COSY. However, unlike the COSY, the 
NOESY experiment observes through-space interactions which provide most of the structural 
information. Protons that are within five angstroms of each other can transfer magnetization 
between each other which generates a cross peak for that interaction in the spectrum. Therefore, 
the NOE is very sensitive to the distance between protons and quickly falls off at a rate of 
1/r6.39,30 The NOESY spectra are more complicated than the COSY spectra, however, assignment 
strategies previously detailed and explained are in place to parse the structural information from 
the data.40 
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CHAPTER II 
Materials and Methods 
Synthesis of Samples 
Unmodified and Complementary Stands: All unmodified oligonucleotides were synthesized by 
Midland Reagent Company (Midland, Texas). 
MeFapy: The MeFapyG modified oligonucleotide was initially synthesized and purified by 
Tracy Salyard-Johnson and Dr. Chanchal Malik, collaborators in the Rizzo laboratory at 
Vanderbilt University. The sequence was 5’-(G1C2T3A4G5T6X7G8G9T10C11C12)-3’ where X7 is 
MeFapyG. Dr. Plamen Christov of the Rizzo lab previously developed the synthetic scheme for 
this sample.21 Briefly, the N7-position of 5’-DMTr-dG is methylated using methyl iodide. To 
achieve the ring opening to MeFapy-dG, the reaction is treated with sodium hydroxide, then the 
base is neutralized with hydrochloric acid. Once the MeFapy-dG nucleoside is synthesized, it is 
then converted into a phosphoramidite so that it can be incorporated into an oligonucleotide via 
solid phase synthesis. 
Aminopyrene: Synthesis and initial purification of the oligonucleotide containing N2-AP-dG was 
accomplished by the research group of Dr. Ashis Basu and Dr. Chanchal Malik at the University 
of Connecticut. The sequence was 5’-(G1T2G3C4X5T6G7T8T9T10G11T12)-3’ where X5 is the N2-
AP-dG adduct. This sequence was selected due to its relevance to codon 273 in the p53 gene.41 
The original synthetic protocol was characterized by Dr. Debasis Chakraborti in Dr. Basu’s lab at 
the University of Connecticut. The synthesis utilized a Buchwald-Hartwig palladium-catalyzed 
amination reaction. Nitropyrene with a leaving group (such as a halogen) was allowed to react 
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with a nucleoside. The optimized cross-coupling reaction was affected by a Pd catalyst, the 
presence of a base, and an electron rich ligand.42 
Ultraviolet-Visible Spectroscopy 
 UV/Vis was used to obtain an optical density (OD) measurement. Ultimately, this would 
provide a concentration of each individual strand. The unmodified and modified strands were 
dried with a Labconco centrivap. For MeFapy, 1.00 mL of pH 7.4 phosphate buffer (10 mM 
phosphate buffer with 0.01 mM EDTA and 100 mM NaCl) was added to the sample. For 
aminopyrene and the unmodified strands, 1.00 mL of milli-pure deionized water was added. The 
samples were subsequently vortexed then centrifuged. A blank cuvette was filled with 1.00 mL 
of the phosphate buffer or water depending on the sample and mixed in the cuvette. Then the 
Varian Cary 100 Bio spectrometer was blanked. Next, 1.00 µL of the DNA sample was added to 
the blank cuvette and an OD reading was obtained. Using the IDT OligoAnalyzer tool, the 
extinction coefficient could be obtained along with the OD to nanomole conversion factors. 
MALDI Mass Spectrometry 
All single strand oligomers, including modified and unmodified, were characterized using 
a Voyager MALDI-TOF instrument. The matrix was composed of 3-hydroxypicolinic acid and 
ammonium hydrogen citrate. All readings were collected in the negative-ion mode. DNA was 
dissolved in 500 µL of milli-pure water. Then 1.00 µL of the DNA was mixed with 10 µL of 3-
hydroxypicolinic acid and 5 µL of ammonium hydrogen citrate. Upon vortexing and 
centrifuging, 1.5 µL of the sample/matrix mixture was plated on a MALDI plate and allowed to 
dry. Upon drying, another 1.00 µL of the sample/matrix mixture was added. 
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Preparation of DNA Duplex 
 Once the concentration of the single-stranded oligonucleotides had been obtained, a 
duplex was made by adding the same concentration (nanomoles) of each strand to a centrifuge 
tube. Upon adding the correct amount of material of both strands to a tube, the DNA sample was 
placed in a heat bath to denature the strands for 10 min. After ten min., the heat bath was turned 
off, and the sample was allowed to sit overnight to ensure that the strands would anneal to form 
the duplex. The optical density of the duplex was checked on UV-Vis. 
High Performance Liquid Chromatography 
Both samples (MeFapy-dG and Aminpyrene) were purified using reverse-phase high 
performance liquid chromatography (RP-HPLC). Initially, each single strand was purified 
separately before being annealing into a duplex. The dried oligomers were suspended in 500 µL 
of deionized water. Aliquots of the sample were then injected onto the HPLC depending on the 
concentration. Upon purification of the single strands, the duplex was formed, and the purity of 
the duplex was checked using HPLC again. 0.1 M, pH 7.0 ammonium formate buffer with 
acetonitrile was used as the mobile phase using gradient elution. The method started at 5% 
acetonitrile and was maintained for 5 minutes. Then from 5 minutes to 55 minutes, the 
acetonitrile ratio was gradually increased to 16% and held for 5 minutes. From 60 minutes to 65 
minutes, the acetonitrile ratio was gradually increased further to 35%. Finally, from 65 to 70 
minutes, the acetonitrile concentration was dropped down to 5% gradually. The column was 
purchased from Phenomenex, and it was a preparative Gemini C-18 250x10 mm column. In 
some runs, an analytical Luna C-18 250x4.6 mm column was used for enhanced purification. 
Once the single strand oligomers were purified, they were annealed to their respective 
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complementary strands. After the purification, the samples were freeze dried using a lyophilizer 
to remove the acetonitrile. 
Hydroxyapatite Anion Exchange Chromatography 
Once the duplexes were formed, a hydroxyapaptite column was employed to separate 
excess single strand oligomers from the duplex. The HAP column acts as an anion exchange 
column which allows further purification of the duplex oligonucleotides. The buffers used in this 
purification were 10 mM and 100 mM sodium phosphate, each with 100 mM NaCl and 0.05 mM 
EDTA. After elution, the samples were dried down in the Labconco centrivap. 
Size Exclusion Chromatography 
The HAP buffers introduced a large concentration of salt to the samples. Therefore, a 
G25 Sephadex desalting column was used to remove the excess salt. This type of column utilizes 
size-exclusion chromatography to separate the duplex (or single strand oligomers) from the salt. 
The sample is dissolved in 1.00 mL of milli-pure water and placed onto the column. Milli-pure 
water is used as the mobile phase with an isocratic method. Ultimately, the sample and salt 
eluted at separates times. After the sample was desalted, the sample was dried down in the 
centrivap. 
Nuclear Magnetic Resonance Spectroscopy 
General: Once the duplexes had been dried down and desalted, the sample was dissolved in 180 
µL of a 10 mM phosphate buffer with 0.01 mM EDTA and 100 mM NaCl (pH 7.4 for MeFapy-
dG, pH 7.0 for N2-AP-dG). The samples were then dried down in the centrivap. In order to 
examine the non-labile protons, a D2O exchange was carried out three times. The sample was 
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then dissolved in 99.996% D2O. All spectra were analyzed using Topspin and Sparky software. 
Furthermore, all unmodified samples correlating to MeFapy-dG and N2-AP-dG were treated in 
the exact same manner. 
Unmodified duplex: NOESY and magnitude COSY experiments were performed on Bruker 800 
(MeFapy-dG) and 900 (N2-AP-dG) MHz instruments at 298 K with 2048 real data points in the t2 
dimension and 512 real data points in the t1 dimension. The NOESY spectra were obtained using 
a mixing time of 250 ms. The NOESY and COSY spectra were zero-filled during processing to 
obtain final matrices of 2048⋅1024 data points. 
MeFapy-dG: Prior to collecting the 2D data, 1D scans were carried out which consisted of 32768 
data points on a 800 MHz Bruker NMR spectrometer at 298 K. Using the same approach 
mentioned for the unmodified duplex, 2D NMR data was collected for the MeFapy-dG sample. 
N2-AP-dG: Prior to collected of 2D data, 1D scans were carried out which consisted of 32768 
data points on a 900 MHz Bruker NMR spectrometer at 298 K. The same approach used for the 
unmodified and MeFapy-dG duplexes was used for the N2-AP-dG duplex. 
NOESY Sequential Walk: The NOESY spectra have a distinct area of the spectrum denoted as 
the “walking region”, and it is representative of interactions between H1’ protons on the sugar 
between H8 protons on purines and H6 protons on pyrimidines. Starting at the 5’-end of each 
individual strand, the interactions between the H1’ and H8/H6 protons can be sequentially 
labeled, or “walked”, all the way to the 3’-end. The figure below illustrates the sequential walk. 
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For unmodified samples, the walk should be continuous since unmodified duplexes 
exhibit typical B-DNA structures. However, it is common for modified duplexes to have breaks 
or discontinuities due to structural perturbations. Once the sequential walk is established, it can 
be used to help assign other cross-peaks throughout the spectrum. 
 
 
 
 
Figure 11. A depiction of the interactions that are analyzed in the NOESY walking region between H1’ of 
the sugar and H8/H6 protons of purines and pyrimidines, respectively. 
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CHAPTER III 
Methyl Formamidopyrimidine Results and Discussion 
Introduction 
Ken Dempster in the Stone laboratory previously analyzed the unmodified version of the 
MeFapy-dG sequence. The NMR assignments were checked further and confirmed. However, 
complete analysis of the modified MeFapy-dG sample had not been completed. The MeFapy-dG 
duplex sequence was 5’-d(G1C2T3A4G5T6X7G8G9T10C11C12)-3’-5’-
d(G13C14A15C16C17C18A19C20T21A22G23C24)-3’. Initial assignments on the modified sample and 
NMR parameters were originally completed and set by Ken Dempster; however, some 
corrections and further assignments were made to the existing data. 
Analysis of the Modified D2O COSY NMR Spectra 
 The unmodified duplex yielded typical B-type DNA behavior, and it acted as a reference 
for the modified duplex. The COSY spectra are used to locate cytosine H5-H6 scalar spin 
couplings. Ultimately, this information is used as a reference point in the more complicated 
NOESY spectra. It is important to note that the COSY spectra contains more structural 
information, but the H5-H6 scalar couplings for cytosine are the primary purpose of using the 
experiment. The data was collected at 298 K on an 800 MHz Bruker spectrometer. 
 The MeFapy-dG sequence contains eight cytosines. Therefore, it would be expected to 
see eight cross-peaks in the COSY spectrum corresponding to the H5-H6 scalar couplings (F1, 
5.10 to 6.15 ppm ;F2, 7.1ppm to 7.85 ppm). This can be seen in Figure 12 below. Interestingly, 
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the C20 cross-peak appears to be broadening, potentially indicating that the base is experiencing 
multiple environments. This could be evidence of the MeFapy lesion’s various rotameric species. 
 
 
Analysis of the Modified D2O NOESY NMR Spectra 
 The modified sample offered some interesting insights. On the modified strand of the 
modified MeFapy sample there were a couple of breaks in the walk indicating structural 
perturbations. For instance, the sequential walk stops after T6, the 5’-neighbor base to the 
MeFapy lesion, and it does not resume until T10. An explanation of this could be that the 
neighboring base cross-peaks have broadened due to various conformations MeFapy-dG can 
adopt, potentially indicating that MeFapy-dG does not adopt a single conformation in solution. 
5’-(G1 C2 T3 A4 G5 T6 X7 G8 G9 T10C11C12)-3’ 
3’-(C24G23A22T21C20A19C18C17C16A15G14G13)-5’ 
Figure 12. H5-H6 scalar coupling region of the MeFapy COSY spectrum taken 
at 298 K on an 800 MHz instrument. 
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Furthermore, the complementary strand exhibits a couple of breaks in the walking region, 
as well. The walk is mostly continuous up until C18 where the cross-peak from C18 H1’ to A19 
H8 has broadened and/or is missing. The walk breaks again at C20 where it does not pick up 
until A22. Therefore, it is obvious that the MeFapy-dG lesion is causing some structural 
perturbations around the lesion site. However, work is still ongoing to determine predominant 
MeFapy-dG structural conformations in solution. 
 
5’-(G1 C2 T3 A4 G5 T6 X7 G8 G9 T10C11C12)-3’ 
3’-(C24G23A22T21C20A19C18C17C16A15G14G13)-5’ 
Figure 13. The NOESY walking region of the modified strand. 
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Parsing out the MeFapy-dG methyl cross-peak amongst the thymine methyl cross-peaks 
was an important step in locating other lesion peaks throughout the spectra. Therefore, work was 
done to conclusively determine which methyl peak belonged to the MeFapy-dG lesion. Figure 
15 below demonstrates the several of the methyl peaks in the MeFapy-dG D2O spectrum. In the 
figure, only one of the MeFapy-dG peaks was conclusively located, and it is labeled as X7Me-
H8. Therefore, this indicates that this a cross-peak of the MeFapy-dG methyl group with the 
formyl (denoted as H8) proton of the lesion. Other methyl peaks belonging to the lesion were 
expected, but they have not been conclusively identified at this time. 
5’-(G1 C2 T3 A4 G5 T6 X7 G8 G9 T10C11C12)-3’ 
3’-(C24G23A22T21C20A19C18C17C16A15G14G13)-5’ 
Figure 14. The NOESY walking region of the complementary strand. 
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Figure 16 illustrates how the MeFapy-dG methyl peak discussed in Figure 15 interacts 
with other known lesion cross-peaks in the spectrum. The top panel of Figure 16 is the methyl 
region. The middle panel is the H2’1/H2’2 region of the spectrum. Finally, the bottom panel is 
adjacent to the diagonal in the 2D NOESY spectrum. The assigned MeFapy-dG methyl cross-
peak aligns with the lesion peaks in the H2’1/H2’2. Interactions can be traced down to the 
diagonal where the formyl proton of the MeFapy-dG is located. The bottom panel shows that the 
signal on the diagonal also lines up with a cross-peak which is an interaction between the formyl 
proton of the lesion and the H6 proton of the 5’-neighboring base, T6. 
5’-(G1 C2 T3 A4 G5 T6 X7 G8 G9 T10C11C12)-3’ 
3’-(C24G23A22T21C20A19C18C17C16A15G14G13)-5’ 
Figure 15. The methyl region of the MeFapy-dG spectrum. 
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Assignments in the modified sample were subsequently compared to assignments in the 
unmodified sample. As previously mentioned, MeFapy-dG can adopt various conformations. 
Therefore, work was done to determine if the two anomers (α and β) were visible in the 
spectrum. Interestingly, the H2’1/H2’2 region offered some valuable insight. Figure 17 shows a 
comparison of the modified (left panel) and the unmodified (right panel) at 298 K. It appears that 
in the modified sample, there is a “doubling” of neighboring base cross-peaks. This provides 
potential evidence of the various anomeric populations of MeFapy-dG in the solution. If this is 
5’-(G1 C2 T3 A4 G5 T6 X7 G8 G9 T10C11C12)-3’ 
3’-(C24G23A22T21C20A19C18C17C16A15G14G13)-5’ 
Figure 16. Tile plot linking interactions of the formyl (H8) proton of the 
MeFapy-dG lesion. 
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the case, the three peaks in the modified sample corresponding to the same chemical shift as the 
three peaks in the unmodified panel would indicate the β-anomer. 
 
 
 
 
 
 
 
 
 
 
T6	H2’1/H2’2-H6	cross	peaks		
T6	H2’1/H2’2-H6	cross	peaks		MeFapy-dG	H2’1/H2’2-H8	cross	peaks	
Figure 17. Comparison of modified (left) and unmodified (right) H2’1/H2’2 region. The modified panel illustrates 
doubling of peaks of the neighboring T6 base. The peaks furthest to the right in the modified sample are the X7 
H2’1-H8 and H2’2-H8 cross-peaks. The doubled peaks are the T6 H2’1-H6 and H2’2-H6 peaks. 
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CHAPTER IV 
N2-Aminopyrene-dG Results and Discussion 
Introduction 
The N2-AP-dG adduct was placed in the 5’-d(G1T2G3C4X5T6G7T8T9T10G11T12)-3’-5’-
d(A13C14A15A16A17C18A19C20G21C22A23C24)-3’ sequence where the adduct is attached to a 
guanine represented as X5. The sequence is biologically significant because it represents codon 
273 in the p53 tumor suppressor gene which is a known mutational hotspot for various cancers.32 
Initially, an unmodified sequence was annealed and analyzed. The unmodified sample would act 
as a control or a basis of comparison for the modified duplex. 
Analysis of the Unmodified D2O NOESY Spectrum 
Figure 18 shows the unmodified strand of the unmodified sample sequential walk. As 
expected, the walk was continuous since the sample was unmodified. The walk can be easily 
traced down the unmodified strand, from 5’à3’ (G1 to T12). This is evidence that the 
unmodified sequence exhibits B-type DNA structure. 
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Similarly to the unmodified strand of the unmodified sample, the complementary strand 
(Figure 19) exhibited an unbroken continuous walk from A13 to C24, indicating B-DNA 
structure. Other regions throughout the spectrum were also assigned, but they are not detailed 
here. 
 
 
 
5’-(G1 T2 G3 C4 G5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
Figure 18. Walking region of the unmodified strand of the unmodified sample at 
308 K on a 900 MHz instrument. 
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Characterization of the Modified N2-AP-dG Duplex 
Once the unmodified duplex was analyzed, data was collected on the modified duplex. 
The first task was to locate the aminopyrene protons in the COSY spectra. The cross-peaks 
located there could then be used in the NOESY to trace interactions between the adduct and the 
DNA. Magnitude COSY spectra were collected at various temperatures. Figure 20 shows the 
aminopyrene cross-peaks at 283 K. Interestingly enough, there only appears to be two adduct 
cross-peaks at this temperature while four were expected. It could be that at certain temperatures 
the scalar couplings between the protons of the adduct are isochronous. 
Figure 19. Walking region of the complementary strand of the unmodified sample 
at 308 K on a 900 MHz instrument. 
5’-(G1 T2 G3 C4 G5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
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Furthermore, if the temperature is increased to 308 K, more dispersion is noted in the 
same region. Figure 21 illustrates this and shows that more cross-peaks are starting to arise. 
Thus, this indicates there is some temperature dependence to the lesion. This dependence could 
be attributed to motion of the adduct, or perhaps the scalar couplings of the adduct protons are 
too low to be fully visualized in a magnitude COSY experiment. Therefore, a separate 
experiment, such as a DQF-COSY would be more beneficial. A magnitude COSY is a great tool 
when the coupling constants are large (such as is the case for the cytosine H5-H6 scalar 
couplings). However, it is not the ideal experiment if the J-constant is lower than 4 Hz. 
 
5’-(G1 T2 G3 C4 X5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
Figure 20. The aminopyrene proton cross-peaks in the magnitude COSY spectrum 
at 283 K on a 900 MHz instrument. 
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To determine if the adduct proton cross-peaks became more intense as the temperature 
was increased, spectra were acquired at other temperatures. The peaks were most dispersed at 
308 K. This can be seen in Figure 22. Therefore, this temperature should be chosen for future 
experiments. 
 
 
 
5’-(G1 T2 G3 C4 X5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
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Figure 21. The aminopyrene proton cross-peaks in the magnitude COSY spectrum 
at 288 K on a 900 MHz instrument. 
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 To be thorough, an extra experiment was ran at 338 K to see what the adduct protons 
were doing once the strands were melted. It can be seen that the dispersion of peaks gained at 
308 K was lost, and only two cross-peaks are observed (similar to the 283 K experiment). It was 
concluded that at very low and very high temperatures, the cross-peaks belonging to the adduct 
protons are isochronous, meaning that they are overlapping at the same chemical shift. The 338 
K COSY is shown in Figure 23. 
 
5’-(G1 T2 G3 C4 X5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
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Figure 22. The aminopyrene proton cross-peaks in the magnitude COSY spectrum 
at 308 K on a 900 MHz instrument. 
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 Once the COSY spectra were obtained, NOESY spectra were collected at 35°C on the 
modified duplex. Since the data demonstrated some unusual characteristics, it is important to 
note that the conclusions derived from the data are preliminary and only speculation. Further 
purification of a new N2-AP-dG duplex is required for further analysis. Figure 24 shows the 
walking region of the modified strand. The walk is continuous up until T6 where it breaks. It can 
be seen that T6 has shifted off of the panel further upfield, meaning that the T6 has become more 
shielded. This could be potential evidence for aminopyrene sitting in the minor groove and 
pointing in the 3’ direction of the modified strand. Therefore, the two peaks that are missing are 
5’-(G1 T2 G3 C4 X5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
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Figure 23. The aminopyrene proton cross-peaks in the magnitude COSY spectrum 
at 338 K on a 600 MHz instrument. 
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the T6 H1’-H6 and T6 H1’-G7 H8 cross-peaks. The walk picks back up at G7 H1’-H8 and 
continues unbroken to the end of the strand. 
 
 
 A closer inspection reveals that the X5 H1’-T6 H6 cross peak lines up with the other T6 
cross-peaks including: T6 Me-H6, T6 H2’1-H6, T6 H2’2-H6, X5 H2’1-T6 H6, and X5 H2’2-T6 
H6. This can be visualized in the NOESY spectrum shown in Figure 25. The large upfield 
chemical shift of the T6 base is indicative of increased shielding. Therefore, this is evidence that 
the AP adduct is sitting in the minor groove, pointing toward the 3’ end of the modified strand. 
5’-(G1 T2 G3 C4 X5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
Figure 24. Walking region of the modified duplex, modified strand at 308 K on a 
900 MHz instrument. 
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More problems are encountered on the complementary strand of the modified duplex. 
Figure 26 shows the walking region of the complementary strand. The walk is continuous from 
A13 to A19, and then it breaks right around C20, which is the base opposite of the adducted 
base. The C20 H5-H6 cross-peak is seen, but the C20 H1’-H6 cross-peak was never located. If 
the C20 base was flipped out like it may be in the case of an intercalated structure, the cross-peak 
would still be present, but it would likely shift further downfield indicating more deshielding of 
the base. However, this is not observed for the aminopyrene sample. It could be that the C20 
H1’-H6 base is overlapped with another cross-peak in the spectrum.  
The walk picks up again at G21. Interestingly, the G21 cross-peaks have broadened out 
significantly throughout the spectrum. The walk breaks again at A23, and the peaks assigned for 
5’-(G1 T2 G3 C4 X5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
Figure 25. T6 connectivities, modified strand at 308 K on a 900 MHz instrument. 
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A23 were highly speculative. Another unusual characteristic is that the C24 peaks have not been 
located. The C24 H5-H6 cross-peak could not be conclusively found in the COSY spectra 
similar to the NOESY spectra. This is unusual, and it is the main reason the conclusions from the 
NOESY data is speculative and not conclusive. 
 
 
 Additional adduct interactions were located throughout the spectrum. For instance, 
interactions between the X5 and the G21 sugars and the adduct provide more evidence to the 
hypothesis that the aminopyrene is oriented in the minor groove. These interactions are shown in 
Figure 27 and Figure 28. 
Figure 26. Walking region of the modified duplex, complementary strand at 308 K 
on a 900 MHz instrument. 
5’-(G1 T2 G3 C4 X5 T6 G7 T8 T9 T10G11T12)-3’ 
3’-(C24A23C22G21C20A19C18A17A16A15C14A13)-5’ 
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Figure 27. Interactions between G21H1’ and AP H2 at 308 K on a 900 MHz 
instrument. 
Figure 28. interactions between X5 H1’ and AP H10 at 308 K on a 900 MHz 
instrument. 
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 Both of the interactions of the adduct with the G21 and X5 sugars provide evidence of the 
aminopyrene sitting in the minor groove, pointing in the 3’-direction of the modified strand. For 
more conclusive results, attention was given to A19 H2. The H2 protons are great markers for 
adducts that are situated in the minor groove. The only way AP could have any cross-peaks with 
A19 would be if it is oriented in the minor groove, pointing in the 3’ direction. Interestingly 
enough, there was a cross peak observed for such an interaction as illustrated in Figure 29. 
 
 
 
 
 
 
 
Figure 29. Interaction of AP H10 with A19 H2 at 308 K on a 900 MHz instrument. 
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CHAPTER V 
Summary 
Methyl Formamidopyrimidine-dG 
 There are significant differences between the unmodified and modified NMR spectra. 
The H1’ walking region indiciates substantial structural perturbation around the lesion site. 
Throughout the spectra, the neighboring bases have their cross-peaks doubled, indicating that 
these bases are experiencing multiple chemical environments. The multiple chemical 
environments could be attributed to the various anomers and rotamers that MeFapy-dG can 
potentially adopt. There is evidence that the doubling of the neighboring base cross-peaks can be 
attributed to the α and β-anomers. Cross-peaks are present that indicate the formyl proton of 
MeFapy-dG interacting with the H6 proton of the neighboring T6 base. This provides evidence 
of at least one rotamer in solution where the methyl group is positioned toward the hydrogen 
bonding interface, and the formyl group is situated closer to the deoxyribose sugar. 
N2-Aminopyrene-dG 
 The unmodified sample demonstrates normal B-type DNA structure. Therefore, it will act 
as a control for future experiments. Various magnitude COSY experiments have shown that 
35°C is an ideal temperature for collecting spectra. At this temperature there is dispersion of the 
adduct protons. Furthermore, this temperature is good for COSY experiments, and it is far from 
the melting temperature of the strand. At very high and very low temperatures, the adduct 
protons appear to be isochronous or severely overlapped. Furthermore, the modified NOESY 
spectra show that T6 has shifted further upfield and has become more shielded, indicating that 
aminopyrene may be oriented in the minor groove, pointing in the 3’-direction of the modified 
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strand. On the complementary strand, cross-peaks associated with C20, A23, and C24 are 
missing or cannot be conclusively assigned which is somewhat unusual in the case of A23 and 
C24. C20 cross-peaks could be overlapped with other cross-peaks in the region. 
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CHAPTER VI 
Future Directions 
Methyl Formamidopyrimidine-dG 
 There is still a plethora of information that should be mined from the NMR spectra. An 
important step in parsing the structural characteristics of MeFapy-dG in solution will be 
determining the predominant conformations. Therefore, an important experiment would be to 
perform an HSQC on the methyl, C13-labeled sample. This sample has already been synthesized. 
By using an HSQC, interactions between the labeled methyl group and nearby protons can be 
assigned and analyzed. It is likely that the lesion may be too complicated for structural 
calculations due to the many rotameric configurations. 
N2-Aminopyrene-dG 
 Purification of a new modified duplex is necessary to parse out conclusive findings. It 
would be exceedingly beneficial to collect DQF-COSY spectra at varying temperatures to 
visualize the adduct protons. As previously mentioned, all of the COSY data presented were 
magnitude COSY spectra. If the adduct proton scalar couplings are below 4 Hz, then it would be 
difficult to see these cross-peaks in the spectrum. To get a full picture, it would be best to collect 
DQF-COSY on the duplex instead of magnitude COSY. Furthermore, more NOESY spectra will 
be needed on the new modified duplex to determine the adduct-DNA interactions conclusively. 
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